| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | ||
|---|---|---|---|---|---|---|
Cash flows from operating activities | ||||||
Net (loss) income | ||||||
4,136 | 54,299 | -35,127 | -313,948 | -81,872 | ||
Adjustments to reconcile net (loss) income to net cash provided by operating activities | ||||||
Depreciation and amortization | ||||||
120,669 | 133,713 | 103,449 | 97,107 | 107,712 | ||
Net loss (gain) on disposal of property and equipment | ||||||
-7,950 | 3,803 | 2,726 | 97 | 760 | ||
Gain realized on previously held interest in Rockwater | ||||||
- | - | 1,210 | - | - | ||
Bad debt expense | ||||||
2,553 | 2,210 | 1,542 | 2,385 | 3,179 | ||
Amortization of debt issuance costs | ||||||
700 | 700 | 4,000 | 3,400 | 576 | ||
Inventory write-downs | ||||||
300 | 400 | - | - | - | ||
Equity-based compensation | ||||||
15,485 | 10,371 | 7,691 | 317 | 692 | ||
Impairment of goodwil and trademarkl | ||||||
4,396 | 17,894 | - | 138,666 | 21,366 | ||
Impairment of property and equipment | ||||||
3,700 | 6,657 | - | 60,026 | - | ||
Impairment of cost-method investment | ||||||
- | 2,000 | - | - | - | ||
Loss on divestitures | ||||||
-3,676 | - | - | - | -972 | ||
Other operating items, net | ||||||
-240 | -1,287 | 353 | 1,619 | 2,340 | ||
Changes in operating assets and liabilities | ||||||
Accounts receivable | ||||||
-57,908 | -36,537 | 100,485 | -1,290 | -140,426 | ||
Prepaid expenses and other assets | ||||||
-11,321 | 9,115 | 2,177 | -1,224 | -3,112 | ||
Accounts payable and accrued liabilities | ||||||
-29,039 | -20,771 | 22,466 | 16,345 | -41,064 | ||
Net cash provided by (used in) operating activities | ||||||
203,948 | 232,409 | -2,899 | 5,131 | 151,999 | ||
Cash flows from investing activities | ||||||
Working capital settlement | ||||||
691 | - | - | - | - | ||
Proceeds received from divestitures | ||||||
24,872 | - | - | - | 400 | ||
Proceeds received from investments | ||||||
- | - | - | - | 830 | ||
Purchase of property and equipment | ||||||
110,143 | 165,360 | 98,722 | 36,290 | 54,076 | ||
Acquisitions, net of cash received | ||||||
10,000 | 16,999 | 65,488 | - | - | ||
Proceeds received from sales of property and equipment | ||||||
17,223 | 13,998 | 7,479 | 9,335 | 14,143 | ||
Net cash used in investing activities | ||||||
-77,357 | -168,361 | -156,731 | -26,955 | -38,703 | ||
Cash flows from financing activities | ||||||
Proceeds from 144A Offering, net of underwriter fees and expenses | ||||||
- | - | - | 297,248 | - | ||
Borrowings from revolving line of credit | ||||||
5,000 | 60,000 | 109,000 | 27,500 | 5,000 | ||
Payments on long-term debt | ||||||
50,000 | 90,000 | 111,000 | 298,000 | 107,000 | ||
Payments of finance lease obligations | ||||||
883 | 1,881 | - | - | - | ||
Payment of debt issuance costs | ||||||
- | - | 3,400 | 4,497 | 1,192 | ||
Proceeds from initial public offering | ||||||
- | - | 140,070 | - | - | ||
Proceeds from share issuance | ||||||
142 | 762 | - | - | - | ||
Payments incurred for initial public offering | ||||||
- | - | 11,566 | - | - | ||
Purchase of noncontrolling interests | ||||||
- | - | - | 348 | - | ||
Contributions from (distributions to) noncontrolling interests | ||||||
-349 | -506 | -368 | 138 | 92 | ||
Repurchase of common stock | ||||||
18,600 | 16,562 | 297 | - | - | ||
Member contributions (distributions) | ||||||
- | - | - | 23,519 | -4,248 | ||
Contingent consideration | ||||||
- | 1,106 | - | - | - | ||
Net cash (used in) provided by financing activities | ||||||
-64,690 | -49,293 | 122,397 | 45,560 | -107,348 | ||
Effect of exchange rate changes on cash | ||||||
130 | -292 | -34 | - | 75 | ||
Net increase (decrease) in cash and cash equivalents | ||||||
62,031 | 14,463 | -37,267 | 23,736 | 6,023 | ||
Supplemental cash flow disclosure: | ||||||
Cash paid for interest | ||||||
2,716 | 5,243 | 1,999 | 12,773 | 10,584 | ||
Cash refunds received for income taxes, net | ||||||
1,793 | -550 | -54 | -192 | 2,262 | ||
Supplemental disclosure of noncash operating activities: | ||||||
Lease liabilities arising from obtaining right-of-use assets | ||||||
119,358 | - | - | - | - | ||
Supplemental disclosure of noncash investing activities: | ||||||
Capital expenditures included in accounts payable and accrued liabilities | ||||||
10,472 | 17,910 | 11,137 | 1,563 | 936 | ||